Go Pro

Senseonics Holdings, Inc. Common Stock (SENS) Competitors

Senseonics Holdings, Inc. Common Stock logo
$5.15 -0.03 (-0.58%)
Closing price 04:00 PM Eastern
Extended Trading
$5.39 +0.24 (+4.66%)
As of 06:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SENS vs. TRNS, FEIM, CTKB, LAB, and PRE

Should you buy Senseonics Holdings, Inc. Common Stock stock or one of its competitors? MarketBeat compares Senseonics Holdings, Inc. Common Stock with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Senseonics Holdings, Inc. Common Stock include Transcat (TRNS), Frequency Electronics (FEIM), Cytek Biosciences (CTKB), Standard BioTools (LAB), and Prenetics Global (PRE).

How does Senseonics Holdings, Inc. Common Stock compare to Transcat?

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Transcat (NASDAQ:TRNS) are related small-cap companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Transcat has a net margin of 0.99% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Transcat's return on equity of 5.56% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Senseonics Holdings, Inc. Common Stock-213.87% -129.97% -67.14%
Transcat 0.99%5.56%3.44%

In the previous week, Transcat had 16 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 18 mentions for Transcat and 2 mentions for Senseonics Holdings, Inc. Common Stock. Transcat's average media sentiment score of 0.98 beat Senseonics Holdings, Inc. Common Stock's score of 0.00 indicating that Transcat is being referred to more favorably in the news media.

Company Overall Sentiment
Senseonics Holdings, Inc. Common Stock Neutral
Transcat Positive

Transcat has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Senseonics Holdings, Inc. Common Stock$35.26M6.11-$69.11M-$2.00N/A
Transcat$331.88M2.67$5.38M$0.58163.00

Senseonics Holdings, Inc. Common Stock presently has a consensus target price of $17.20, indicating a potential upside of 233.98%. Transcat has a consensus target price of $105.50, indicating a potential upside of 11.59%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher possible upside, research analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Transcat.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50
Transcat
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Senseonics Holdings, Inc. Common Stock has a beta of 1.01, suggesting that its stock price is 1% more volatile than the broader market. Comparatively, Transcat has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market.

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. Comparatively, 98.3% of Transcat shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Comparatively, 1.8% of Transcat shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Transcat beats Senseonics Holdings, Inc. Common Stock on 10 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Frequency Electronics?

Frequency Electronics (NASDAQ:FEIM) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are related small-cap companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership.

58.6% of Frequency Electronics shares are owned by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 28.0% of Frequency Electronics shares are owned by company insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Frequency Electronics has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Frequency Electronics is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Frequency Electronics$63.23M11.61-$900K-$0.09N/A
Senseonics Holdings, Inc. Common Stock$35.26M6.11-$69.11M-$2.00N/A

Frequency Electronics has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.01, indicating that its share price is 1% more volatile than the broader market.

Frequency Electronics has a net margin of -1.43% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Frequency Electronics' return on equity of -1.56% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Frequency Electronics-1.43% -1.56% -0.98%
Senseonics Holdings, Inc. Common Stock -213.87%-129.97%-67.14%

In the previous week, Frequency Electronics had 3 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 5 mentions for Frequency Electronics and 2 mentions for Senseonics Holdings, Inc. Common Stock. Frequency Electronics' average media sentiment score of 0.71 beat Senseonics Holdings, Inc. Common Stock's score of 0.00 indicating that Frequency Electronics is being referred to more favorably in the media.

Company Overall Sentiment
Frequency Electronics Positive
Senseonics Holdings, Inc. Common Stock Neutral

Frequency Electronics currently has a consensus target price of $43.67, suggesting a potential downside of 41.31%. Senseonics Holdings, Inc. Common Stock has a consensus target price of $17.20, suggesting a potential upside of 233.98%. Given Senseonics Holdings, Inc. Common Stock's higher possible upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Frequency Electronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Frequency Electronics
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Frequency Electronics beats Senseonics Holdings, Inc. Common Stock on 13 of the 17 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Cytek Biosciences?

Cytek Biosciences (NASDAQ:CTKB) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.

In the previous week, Cytek Biosciences had 6 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 8 mentions for Cytek Biosciences and 2 mentions for Senseonics Holdings, Inc. Common Stock. Cytek Biosciences' average media sentiment score of 0.50 beat Senseonics Holdings, Inc. Common Stock's score of 0.00 indicating that Cytek Biosciences is being referred to more favorably in the media.

Company Overall Sentiment
Cytek Biosciences Positive
Senseonics Holdings, Inc. Common Stock Neutral

Cytek Biosciences has a net margin of -38.98% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Cytek Biosciences' return on equity of -12.16% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Cytek Biosciences-38.98% -12.16% -9.07%
Senseonics Holdings, Inc. Common Stock -213.87%-129.97%-67.14%

Cytek Biosciences has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.01, meaning that its share price is 1% more volatile than the broader market.

Cytek Biosciences currently has a consensus price target of $5.69, indicating a potential upside of 36.72%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.20, indicating a potential upside of 233.98%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher probable upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Cytek Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cytek Biosciences
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

69.5% of Cytek Biosciences shares are held by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 10.4% of Cytek Biosciences shares are held by company insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Cytek Biosciences has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Cytek Biosciences is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cytek Biosciences$201.49M2.67-$66.54M-$0.62N/A
Senseonics Holdings, Inc. Common Stock$35.26M6.11-$69.11M-$2.00N/A

Summary

Cytek Biosciences beats Senseonics Holdings, Inc. Common Stock on 11 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Standard BioTools?

Standard BioTools (NASDAQ:LAB) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

In the previous week, Standard BioTools had 2 more articles in the media than Senseonics Holdings, Inc. Common Stock. MarketBeat recorded 4 mentions for Standard BioTools and 2 mentions for Senseonics Holdings, Inc. Common Stock. Senseonics Holdings, Inc. Common Stock's average media sentiment score of 0.00 beat Standard BioTools' score of -0.27 indicating that Senseonics Holdings, Inc. Common Stock is being referred to more favorably in the news media.

Company Overall Sentiment
Standard BioTools Neutral
Senseonics Holdings, Inc. Common Stock Neutral

53.7% of Standard BioTools shares are owned by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 26.8% of Standard BioTools shares are owned by company insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Standard BioTools has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.01, suggesting that its stock price is 1% more volatile than the broader market.

Standard BioTools has a net margin of 100.36% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Standard BioTools' return on equity of -7.89% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Standard BioTools100.36% -7.89% -6.26%
Senseonics Holdings, Inc. Common Stock -213.87%-129.97%-67.14%

Senseonics Holdings, Inc. Common Stock has lower revenue, but higher earnings than Standard BioTools. Senseonics Holdings, Inc. Common Stock is trading at a lower price-to-earnings ratio than Standard BioTools, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Standard BioTools$85.33M3.66-$74.90M$0.223.64
Senseonics Holdings, Inc. Common Stock$35.26M6.11-$69.11M-$2.00N/A

Standard BioTools currently has a consensus price target of $1.35, suggesting a potential upside of 68.73%. Senseonics Holdings, Inc. Common Stock has a consensus price target of $17.20, suggesting a potential upside of 233.98%. Given Senseonics Holdings, Inc. Common Stock's stronger consensus rating and higher probable upside, analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than Standard BioTools.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Standard BioTools
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Standard BioTools beats Senseonics Holdings, Inc. Common Stock on 10 of the 16 factors compared between the two stocks.

How does Senseonics Holdings, Inc. Common Stock compare to Prenetics Global?

Prenetics Global (NASDAQ:PRE) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) are related small-cap companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment.

In the previous week, Prenetics Global and Prenetics Global both had 2 articles in the media. Prenetics Global's average media sentiment score of 0.00 equaled Senseonics Holdings, Inc. Common Stock'saverage media sentiment score.

Company Overall Sentiment
Prenetics Global Neutral
Senseonics Holdings, Inc. Common Stock Neutral

Prenetics Global has a net margin of -62.45% compared to Senseonics Holdings, Inc. Common Stock's net margin of -213.87%. Prenetics Global's return on equity of -20.33% beat Senseonics Holdings, Inc. Common Stock's return on equity.

Company Net Margins Return on Equity Return on Assets
Prenetics Global-62.45% -20.33% -15.42%
Senseonics Holdings, Inc. Common Stock -213.87%-129.97%-67.14%

Prenetics Global has higher revenue and earnings than Senseonics Holdings, Inc. Common Stock. Prenetics Global is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Prenetics Global$92.39M3.26-$37.71M-$4.58N/A
Senseonics Holdings, Inc. Common Stock$35.26M6.11-$69.11M-$2.00N/A

Prenetics Global presently has a consensus target price of $34.25, suggesting a potential upside of 91.77%. Senseonics Holdings, Inc. Common Stock has a consensus target price of $17.20, suggesting a potential upside of 233.98%. Given Senseonics Holdings, Inc. Common Stock's higher possible upside, analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Prenetics Global.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Prenetics Global
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Senseonics Holdings, Inc. Common Stock
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

25.0% of Prenetics Global shares are owned by institutional investors. Comparatively, 12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. 7.8% of Prenetics Global shares are owned by insiders. Comparatively, 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Prenetics Global has a beta of 0.26, suggesting that its share price is 74% less volatile than the broader market. Comparatively, Senseonics Holdings, Inc. Common Stock has a beta of 1.01, suggesting that its share price is 1% more volatile than the broader market.

Summary

Prenetics Global beats Senseonics Holdings, Inc. Common Stock on 8 of the 13 factors compared between the two stocks.

Get Senseonics Holdings, Inc. Common Stock News Delivered to You Automatically

Sign up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SENS vs. The Competition

MetricSenseonics Holdings, Inc. Common StockHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$216.54M$5.82B$6.95B$12.87B
Dividend YieldN/A1.79%2.59%9.95%
P/E Ratio-2.5824.30270.8225.32
Price / Sales6.1165.38599.7483.17
Price / CashN/A32.4371.8950.37
Price / Book3.465.5413.006.13
Net Income-$69.11M$149.64M$3.46B$342.95M
7 Day Performance1.58%3.36%2.64%3.03%
1 Month Performance-8.53%-1.73%-2.64%-3.04%
1 Year PerformanceN/A8.89%76.00%20.65%

Senseonics Holdings, Inc. Common Stock Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SENS
Senseonics Holdings, Inc. Common Stock
2.3056 of 5 stars
$5.15
-0.6%
$17.20
+234.0%
N/A$216.54M$35.26MN/A90
TRNS
Transcat
2.9528 of 5 stars
$81.35
-5.5%
$105.50
+29.7%
+23.9%$805.60M$331.88M140.261,413
FEIM
Frequency Electronics
1.2287 of 5 stars
$57.69
-13.2%
$43.67
-24.3%
+159.2%$655.97M$63.23MN/A200
CTKB
Cytek Biosciences
2.5132 of 5 stars
$4.38
-1.8%
$5.69
+29.9%
+7.7%$575.98M$201.49MN/A500
LAB
Standard BioTools
3.2896 of 5 stars
$0.87
+10.0%
$1.35
+54.5%
-39.7%$310.23M$85.33M4.37620

Related Companies and Tools


This page (NASDAQ:SENS) was last updated on 8/6/2026 by MarketBeat.com Staff.
From Our Partners